Integrase strand transfer inhibitors
Effect of HIV-1 Integrase Resistance Mutations When Introduced into SIVmac239 on Susceptibility to Integrase Strand Transfer Inhibitors
10
Mutations Located outside the Integrase Gene Can Confer Resistance to HIV 1 Integrase Strand Transfer Inhibitors
11
Characterization of the Drug Resistance Profiles of Integrase Strand Transfer Inhibitors in Simian Immunodeficiency Virus SIVmac239
12
Prevalence of resistance to integrase strand transfer inhibitors (INSTIs) among untreated HIV 1 infected patients in Morocco
8
Altered Viral Fitness and Drug Susceptibility in HIV-1 Carrying Mutations That Confer Resistance to Nonnucleoside Reverse Transcriptase and Integrase Strand Transfer Inhibitors
9
Differential Sensitivities of Retroviruses to Integrase Strand Transfer Inhibitors
6
The Combination of the R263K and T66I Resistance Substitutions in HIV-1 Integrase Is Incompatible with High-Level Viral Replication and the Development of High-Level Drug Resistance
6
Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS
14
Switch rates, time to switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital claim database
11
Viral fitness cost prevents HIV 1 from evading dolutegravir drug pressure
7
In vitro activity of dolutegravir against wild type and integrase inhibitor resistant HIV 2
9
HIV drug resistance against strand transfer integrase inhibitors
16
Lack of integrase inhibitors associated resistance mutations among HIV 1C isolates
8
Inhibitors of the integrase–transportin SR2 interaction block HIV nuclear import
13
Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitroand provide a rationale to redesign antiretroviral treatment for feline AIDS
13
Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors
9
Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection
10
Allosteric Integrase Inhibitors Reveal a Role for Integrase During HIV-1 Maturation
190
Raltegravir, elvitegravir, and metoogravir: the birth of "me too" HIV 1 integrase inhibitors
14
Patterns of resistance development with integrase inhibitors in HIV
12